-
Vinci Pharmaceuticals Secures Over $8 Million in Series A Funding for EpiPlant Platform
A Major Milestone for Drug Delivery Innovation Vinci Pharmaceuticals Inc. has officially announced the successful completion of its Series A financing round, securing more than $8 million USD. This significant capital injection marks a pivotal moment for the company as it moves to accelerate the development of its proprietary technology. Advancing the EpiPlant Platform The…